The role of PET/CT in determining egfr mutation and ALK rearrangement in patients with lung adenocarcinoma . Ann Med Res . 2021;27(2):0634-0640. Accessed April 5, 2025. http://annalsmedres.org/index.php/aomr/article/view/607